Enhancing B-Cell Malignancies—On Repurposing Enhancer Activity towards Cancer

SIMPLE SUMMARY: B-cell malignancies are a heterogenous group of lymphomas and leukemias and are the 6th most common cancer-related cause of death. Apart from several oncogenes and tumor suppressors involved in their pathogenesis, recently the role of non-coding, regulatory sequences has been implied...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasprzyk, Marta Elżbieta, Sura, Weronika, Dzikiewicz-Krawczyk, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269369/
https://www.ncbi.nlm.nih.gov/pubmed/34210001
http://dx.doi.org/10.3390/cancers13133270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269369/
https://www.ncbi.nlm.nih.gov/pubmed/34210001
http://dx.doi.org/10.3390/cancers13133270

Ejemplares similares